期刊文献+

体外循环前后人肺静脉血中MMP-9和TIMP-1表达及浓度变化 被引量:5

Expression and concentration change of matrix metaloproteinase-9 and tissue in habitor of metalloproteinase-1 in human pulmonary vein blood after cardiopulmonary bypass
下载PDF
导出
摘要 目的探讨体外循环前后人肺静脉血中基质金属蛋白酶9(MMP-9)和金属蛋白酶组织抑制因子(TIMP-1)表达及浓度变化。方法选择25例接受心脏手术的患者,其中20例在体外循环下手术,5例未在体外循环下手术。于体外循环(CPB)开始时(进胸时)、CPB结束时(关胸时)在肺静脉采取血标本,用酶联法(ELISA)检测各个标本血浆中MMP-9及TIMP-1的浓度;用逆转录聚合链反应(RT-PCR)测定MMP-9、TIMP-1的表达。结果CPB后人肺静脉血中MMP-9/TIMP-1明显升高,白细胞MMP-9表达及浓度增加,TIMP-1浓度及表达下降,而未经CPB的患者肺静脉血中MMP-9和TIMP-1表达及浓度无明显变化。结论鉴于MMP-9特异性降解作用,推测MMP-9、TIMP-1的变化与CPB后肺损伤的病理变化可能有一定关联。 Objective To elucidate expression and concentration change of matrix metaloproteinase(MMP) -9 and tissue inhabitor of metalloproteinase(TIMP) -1 in human pulmonary vein blood after cardiopulmonary bypass (CPB). Methods Total 25 patients who have performed the heart surgery were choosed in our study,and among them,20 patients were underwent external circulation while 5 patients were not received CPB. Human blood samples were collected from the pulmonary vein at the commence of CPB ( or of surgery) and the termination of CPB ( or of surgery) respectively. Enzyme - linked immunosorbent assay (ELISA) and reverse transcription -polymerase chain reaction ( RT - PCR) was used for detection of MMP -9 and TIMP - 1. Results After CPB,the ratio of MMP - 9/TIMP - 1 increaed;expression and concentration of MMP -9 signicantly increased, and TIMP - 1 in plasma decreased;however, MMP -9 and TIMP - 1 did not change after surgery without undergoing CPB. Conclusion MMP -9 ,TIMP - 1 may be involved in the pathogenesis of lung injury undergoing cardiopulmonary bypass.
出处 《安徽医学》 2006年第6期446-448,共3页 Anhui Medical Journal
基金 安徽省教育厅自然科学研究项目基金(编号:2001kj135)
关键词 体外循环 基质金属蛋白酶-9 金属蛋白酶组织抑制因子-1 Cardiopulmonary bypass Matrix metaloproteinase - 9 Tissue inhabitor of metalloproteinase - 1
  • 相关文献

参考文献10

  • 1Cremer J,Martin M,Redl H,et al.Systemic inflammatory response syndrome after cardiac operations.Ann Thorac Surg,1996 ;61 (6):1714~20
  • 2Asimakopoulos G,Smith PL,Ratnatunga CP,et al.Lung injury and acute respiratory distress syndrome after cardio-pulmonary bypass.Ann Thorac Surg,1999;68(3):1107~15
  • 3Camey DE,Lutz CL,Picone AL,et al.Matrix metaloproteinase inhibitor prevents acute lung injury after cardiopulmonary bypass.Circulation,1999; 100 (4):400~406
  • 4Movies TJ,Chow CW,Downey GP.Proteases and lung in jury.Crit Care Mod,2003; 31 (4 Suppl):S189~94
  • 5Joffs C,Gunasinghe HR,Multani MM,et al.Cardiopulmonary bypass induces the synthesis and release of matrix metalloproteinases.Ann Thorac Surg,2001 ;71:1518 ~23
  • 6Galley HF,Macaulay GD,Webster NR.Matrix metalloproteinase -9,tissue inhabitor of metalloproteinase-1 and tumour necrosis factor alpha release during cardiopulmonary bypass.Anaesthesia,2002 ;57:659~62
  • 7王寿勇,张诗海,姚尚龙.体外循环前后人白细胞基质金属蛋白酶9基因表达及血浆浓度的变化[J].中华医学杂志,2005,85(8):566-568. 被引量:4
  • 8王常田,景华,李忠东,胡小南,董国华,钱建军,罗立国,顾卫东.体外循环急性肺损伤与基质金属蛋白酶-9相关性研究[J].实用临床医药杂志,2003,7(6):514-516. 被引量:1
  • 9Tso-Chou Lin,Chi-Yuan Li,Chien-Sung Tsai,et al.Neutrophil-Mediated Secretion and Activation of Matrix Metalloproteinase-9 During Cardiac Surgery with Cardiopulmonary Bypass.Anesth Analg,2005; 100:1554~60
  • 10Gipson TS,Bless NM,Shanley TP,et al.Regulatory effects of endogenous protease inhibitors in acute lung inflammatory injury.J Immunol,1999; 162 (6):3653~62

二级参考文献13

  • 1张诗海,姚尚龙.Effects of Intraoperative Autologous Blood Donation and Tepid Temperature Cardiopulmonary Bypass on Blood System[J].Journal of Huazhong University of Science and Technology(Medical Sciences),2000,20(2):151-153. 被引量:3
  • 2Hozumi A, Nishimura Y, Nishiuma T, et al. Induction of MMP-9 in normal human bronchial epithelial cells by TNF-alpha via NF-kappa B-mediated pathway[J]. Am J Physiol Lung Cell Mol Physiol, 2001, 281: L1444.
  • 3Vaday G G, Hershkoviz R, Rahat M A, et al. Fibronectin-bound TNF-alpha stimulates monocyte matrix metalloproteinase-9 expression and regulates chemotaxis[J]. J Leukoc Biol, 2000, 68: 737.
  • 4Black R A, Rauch C T, Kozlosky C J, et al. A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells[J]. Nature, 1997, 385: 729.
  • 5Mohan M J, Seaton T, Mitchell J, et al. The tumor necrosis factor-alpha converting enzyme (TACE): a unique metalloproteinase with highly defined substrate selectivity[J]. Biochemistry, 2002, 41: 9462.
  • 6Milot J, Perron J, Lacasse Y, et al. Incidence and predictors of ARDS after cardiac surgery[J]. Chest, 2001, 119: 884.
  • 7Carney D E, Lutz C J, Picone A L, et al. Matrix metalloproteinase inhibitor prevents acute lung injury after cardiopulmonary bypass[J]. Circulation, 1999, 100: 400.
  • 8Alexander J S, Elrod J W. Extracellular matrix, junctional integrity and matrix metalloproteinase interactions in endothelial permeability regulation[J]. J Anat, 2002, 200: 561.
  • 9Cuzner M L, Opdenakker G. Plasminogen activators and matrix metalloproteases, mediators of extracellular proteolysis in inflammatory demyelination of the central nervous system[J]. J Neuroimmunol. 1999, 94: 1.
  • 10Hussain S, Assender J W, Bond M, et al. Activation of protein kinase Czeta is essential for cytokine-induced metalloproteinase-1, -3, and -9 secretion from rabbit smooth muscle cells and inhibits proliferation[J]. J Biol Chem, 2002, 277: 27345.

共引文献3

同被引文献60

  • 1董文珠,李兆申,邹多武,屠振兴,龚燕芳,金晶.基质金属蛋白酶抑制剂BB-94对急性胰腺炎及其相关性肺损伤的影响[J].胰腺病学,2005,5(1):36-39. 被引量:3
  • 2王寿勇,张诗海,姚尚龙.体外循环前后人白细胞基质金属蛋白酶9基因表达及血浆浓度的变化[J].中华医学杂志,2005,85(8):566-568. 被引量:4
  • 3Ng CS, Wan S, Yim AP, et al. Pulmonary dysfunction after cardiac surgery[J]. Chest,2002,121 (4) :1269-1277.
  • 4Chen F,Nakamura T,Fujinaga T ,et al. Protective effect of a nebulized beta2- adrenoreceptor agonist in warm ischemic-reperfused rat lungs [J]. Ann Thorac Surg,2006,82 (2) :465471.
  • 5Cremer J, Martin M, Redl H, et al. Systemic inflammatory response syndrome after cardiac operations[ J]. Ann Thorae Surg, 1996,61 (6) :1714-1720.
  • 6Steinberg J, Fink G, Picone A, et al. Evidence of increased matrix metalloproteinase-9 concentration in patients following cardiopulmo-nary bypass[ J]. J Extra Corpor Technol,2001,33 (4) :218-222.
  • 7Carney DE, Lutz C J, Picone AL, et al. Matrix metalloproteinase in-hibitor prevents acute lung injury after cardiopulmonary bypass [ J ]. Circulation, 1999,1 00 (4) : 400-406.
  • 8Kleiner DE,Stetler-Stevenson WG. Matrix metalloproteinases and metastasis. Cancer Chemother Pharmacol, 1999, 43 (Suppl) :S42-S51.
  • 9Carden D, Xiao F, Moak C, et al. Neutrophil elastase promotes lung mierovaseular injury and proteolysis of endothelial eadherins. Am J Physiol, 1998,275 : H385-H392.
  • 10Nagase H,Woessner JF Jr. Matrix metalloproteinases. J Biol Chem, 1999,274:21491-21494.

引证文献5

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部